Gland Pharma Ltd IPO

IPO Synopsis

Gland Pharma Limited, one of the fastest growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report) is coming up with its initial public offering (IPO). The issue is all set to open on 9th Nov' 2020 and the close date is 11th Nov' 2020. The price band of the Offer has been fixed at Rs. 1,490 to Rs. 1,500 per Equity Share.

Initial public offer of up to 34,863,635 equity shares of face value of Rs. 1 each (equity shares) of Gland Pharma Limited (Company or Issuer) for cash at a price of Rs.1,490 to Rs. 1,500 Per equity share (including a share premium of Rs.[*] per equity share) aggregating up to Rs.[*] crores (The Offer) comprising a fresh issue of up to 8,333,333 equity shares aggregating up to Rs. 1250.00 crores on (The fresh issue) and an offer for sale of up to 34,863,635 equity shares, including up to 19,368,686 equity shares by Fosun Pharma Industrial Pte. Ltd (promoter selling shareholder) and up to 10,047,435 equity shares by Gland Celsus Bio Chemicals Private Limited, up to 3,573,014 equity shares By Empower Discretionary Trust, and up to 1,874,500 equity shares by Nilay Discretionary Trust (collectively, the other selling shareholders and collectively With the promoter selling shareholder are referred to as the selling shareholders, and such equity shares, the offered shares) aggregating up to Rs.[*] crores (the offer for sale). The offer shall constitute [*]% of the post-offer paid-up equity share capital of the company.

Gland Pharma Ltd IPO Frequently Asked Questions

Read more IPO FAQs